banda transcan

The previous ERA-NET on translational cancer research TRANSCAN was funded by the European Commission under the FP7 from 2011 to 2014.

The network, coordinated by Italy (Ministry of Health), was comprised of  25 partners from 19 countries.

The main objective of TRANSCAN was to coordinate national and regional translational cancer research funding organisations' activities, aiming at the integration of basic, clinical and epidemiological cancer research and facilitation of coordinated, transnational cancer funding in Europe with the ultimate aim to streamline EU-wide cancer screening, early diagnosis, prognosis, treatment and care.

The specific objectives of TRANSCAN have been achieved through the implementation of interconnected activities, structured into the following six work packages:

Work Package 1 - Management and network coordination (Leader: MoH-ISS, Italy)
Work Package 2 - Survey and analysis of national cancer research funding of translational cancer research (Leader: CR-UK, United Kingdom)
Work Package 3 - Preparation of joint transnational calls (JTCs) (Leader: ISCIII, Spain)
Work Package 4 - Implementation of joint transnational calls (JTCs) (Leader: DLR, Germany)
Work Package 5 - Implementation of capacity building & training activities (Leader: INCa, France)
Work Package 6 - Monitoring of activities & network sustainability (Leader: FCT, Portugal)

In the frame of TRANSCAN, three Joint Transnational Calls were launched

JTC 2011
JTC 2012
JTC 2013


TRANSCAN News

Launch of the call: JTC 2021
The new TRANSCAN-3 project consortium is launching the first Joint Transnational Call for proposals, co-funded by the European Commission, on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment"

International Networking Event (virtual)
on 22 April 2021 hrs 9:00 CET
will focus on the forthcoming co-funded JTC 2021 on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment" 
the event is organized by TUBITAK under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project
in cooperation with TRANSCAN-3

ERA-NET Cofund TRANSCAN-3:
 Sustained collaboration of national and regional programmes in cancer research
is the new project funded by the European Commission under H2020  which started on 1st March 2021 and will last five years (G. A. no. 964264)

A TRANSCAN-2 brochure, highlighting key achievements, is available for download

 

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.